Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

14th International Myeloma Workshop /
Challenging paradigms in multiple myeloma

3rd - 7th Apr 2013

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 06.04.13
Views: 5552

Prof Antonio Palumbo - University of Torino, Italy

Prof Antonio Palumbo of University of Torino, Italy talks to ecancertv at IMW 2013 on treating special population in multiple myeloma (MM) as a significant problem. This group increasing includes the elderly as the population ages. It is therefore important to understand how best to tailor treatment for these patients. Professor Palumbo has been involved in a number of key studies in elderly patients with MM. High risk patients are currently managed in the same way as standard risk patients, with a view to providing the best chance of progression free survival and overall survival in this patient population. In newly diagnosed elderly patients the benefits of carfilzomib have been investigated. In addition, lenalidomide has been tested in these patients. Relapsed or refractory patients can be a particular challenge in the clinical setting. Pomalidomide is a new therapy that is currently been investigated in this difficult to treat population.

This programme has been supported by an unrestricted educational grant from Janssen Pharmaceutica (A Johnson & Johnson Company).

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation